Which has the lower trailing P/E, DGX or MTD?

DGX has the lower trailing P/E: DGX trades at 25.30 and MTD at 32.13. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DGX or MTD?

Over the past five years, MTD grew revenue faster — DGX at a 0.89% CAGR versus MTD at 3.54%.

Does DGX or MTD pay a bigger dividend?

DGX pays a dividend (1.39% yield), while MTD has no payments in the available dividend history.

Is DGX or MTD more profitable?

MTD runs the higher net margin — DGX at 9.19% versus MTD at 21.91%.

How have DGX and MTD total returns compared?

Over the past 10 years, DGX delivered 12.97% and MTD delivered 13.61% annualized total return. Past performance doesn't predict future results.

Quest Diagnostics Incorporated (DGX) vs Mettler-Toledo International Inc. (MTD)

A side-by-side comparison of Quest Diagnostics Incorporated and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

DGX

Quest Diagnostics Incorporated

$26.23B

$237.62HealthcareDelayed quote: Aug 10, 2026, 1:20 PM EDT

MTD

Mettler-Toledo International Inc.

$29.08B

$1,439.08HealthcareDelayed quote: Aug 10, 2026, 1:15 PM EDT

Total return — DGX vs MTD

growth of $100 · dividends reinvested · last 10y

DGX +236.1% (+12.9%/yr)MTD +257.3% (+13.6%/yr)MTD compounded faster over this window

DGX MTD

DGX vs MTD: by the numbers

•MTD is the larger company ($29.08B vs $26.23B market cap).
•DGX trades at the lower trailing earnings multiple (25.30 vs 32.13 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.91% vs 9.19% net margin).
•MTD grew revenue faster over the past five years (3.54% vs 0.89% CAGR).
•DGX pays a dividend (1.39% yield), while MTD has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DGX	MTD
P/E ratio	25.30	32.13
Forward P/E	21.30	30.35
P/S ratio	2.31	6.97
P/B ratio	3.55	2248.06
EV / EBITDA	16.25	23.45
FCF yield	4.57%	3.00%

Profitability

Metric	DGX	MTD
Gross margin	33.15%	59.30%
Operating margin	14.14%	28.69%
Net margin	9.19%	21.91%
ROE	14.13%	7062.40%
ROIC	8.43%	35.46%

Dividends

Metric	DGX	MTD
Dividend yield	1.39%	N/A
Payout ratio	37.43%	N/A

Growth (annualized)

Metric	DGX	MTD
Revenue CAGR (5Y)	0.89%	3.54%
EPS CAGR (5Y)	-3.65%	10.81%
FCF CAGR (5Y)	-10.89%	2.13%
Total return CAGR (5Y)	12.37%	-1.24%

Frequently asked

Which has the lower trailing P/E, DGX or MTD?: DGX has the lower trailing P/E: DGX trades at 25.30 and MTD at 32.13. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DGX or MTD?: Over the past five years, MTD grew revenue faster — DGX at a 0.89% CAGR versus MTD at 3.54%.
Does DGX or MTD pay a bigger dividend?: DGX pays a dividend (1.39% yield), while MTD has no payments in the available dividend history.
Is DGX or MTD more profitable?: MTD runs the higher net margin — DGX at 9.19% versus MTD at 21.91%.
How have DGX and MTD total returns compared?: Over the past 10 years, DGX delivered 12.97% and MTD delivered 13.61% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DGX analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

Quest Diagnostics P/E ratio Mettler-Toledo International P/E ratio Quest Diagnostics dividend yield Quest Diagnostics ROE Mettler-Toledo International ROE Quest Diagnostics operating margin Mettler-Toledo International operating margin Quest Diagnostics revenue growth Mettler-Toledo International revenue growth Quest Diagnostics free cash flow Mettler-Toledo International free cash flow

Quest Diagnostics & Mettler-Toledo International appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.